Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk
- Status
- TERMINATED
- Phase
- NA
CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum
- Status
- COMPLETED
- Phase
- PHASE2
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2